CRRTF News and Press, Coronet Carpets Inc From 04/25/19

Crescita Therapeutics ( OTC:CRRTF ) inks an agreement with Cantabria Labs for exclusive commercial rights to topical anesthetic cream Pliaglis (lidocaine and tetracaine) in Italy, Portugal, Spain and France. More news on: Crescita Therapeutics Inc., Healthcare stocks news, Read more ...

Crescita Therapeutics Signs Pliaglis® Out-Licensing Agreement with Cantabria Labs for €2.5M Upfront After Reacquiring Rest-of-World Rights Canada NewsWire LAVAL, QC, April 25, 2019 LAVAL, QC , April 25, 2019 /CNW Telbec/ - Crescita Therapeutics Inc. ("Cre...

Crescita Therapeutics to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference in Toronto Crescita Therapeutics to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference in Toronto Canada NewsWire LAVAL, QC, April 17, 2019 LAVAL, QC ...

Crescita Therapeutics ( OTC:CRRTF ): Q4 GAAP EPS of C$0.15. More news on: Crescita Therapeutics Inc., Earnings news and commentary, , Read more ...

Crescita Therapeutics ( OTC:CRRTF ) and Tetra Natural Health, a subsidiary of Tetra Bio-Pharma ( OTCQB:TBPMF ) collaborates to develop an enhanced version of Tetra's dermatology portfolio using Crescita's patented transdermal delivery technologies: Multiplexed Molecular Penetration Enhancer ...